Braster S.A. Stock

Equities

BRA

PLBRSTR00014

Biotechnology & Medical Research

Market Closed - Warsaw S.E. 11:55:55 2024-04-24 am EDT 5-day change 1st Jan Change
0.58 PLN 0.00% Intraday chart for Braster S.A. 0.00% 0.00%
Sales 2021 436K 108K Sales 2022 2.24M 554K Capitalization 22.06M 5.45M
Net income 2021 -6M -1.48M Net income 2022 -3M -741K EV / Sales 2021 82.6 x
Net Debt 2021 13.35M 3.3M Net Debt 2022 12.42M 3.07M EV / Sales 2022 15.4 x
P/E ratio 2021
-3.39 x
P/E ratio 2022
-5.18 x
Employees 14
Yield 2021 *
-
Yield 2022
-
Free-Float 76.08%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.57
Extreme 0.568
0.67
3 years
0.53
Extreme 0.534
1.52
5 years
0.19
Extreme 0.192
2.88
10 years
0.19
Extreme 0.192
30.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 09-12-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
More insiders
Date Price Change Volume
24-04-23 0.58 0.00% 0
24-04-22 0.58 0.00% 0
24-04-19 0.58 0.00% 0
24-04-18 0.58 0.00% 0
24-04-17 0.58 0.00% 0

Delayed Quote Warsaw S.E., April 24, 2024 at 11:55 am EDT

More quotes
Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.
More about the company